
    
      The trial is designed to provide additional evidence regarding appropriate recommendations
      for use of the MitraClip System for patients with chronic heart failure and clinically
      significant functional mitral regurgitation. Additionally, the trial will collect evidence
      regarding health economics of the MitraClip System for use in this patient population.
    
  